| Original language | English |
|---|---|
| Pages (from-to) | 111-188 |
| Number of pages | 78 |
| Journal | European heart journal |
| Volume | 41 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2020 |
Keywords
- Apolipoprotein B
- Cholesterol
- Dyslipidaemias
- Familial hypercholesterolaemia
- Guidelines
- High-density lipoproteins
- Lipoprotein remnants
- Lipoprotein(a)
- Low-density lipoproteins
- Total cardiovascular risk
- Treatment (adherence)
- Treatment (drugs)
- Treatment (lifestyle)
- Triglycerides
- Very low-density lipoproteins
Research output
- 1 Comment/Letter to the editor
-
Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., Graham, I. M., Halliday, A., Landmesser, U., Mihaylova, B., Pedersen, T. R., Riccardi, G., Richter, D. J., Sabatine, M. S., Taskinen, M. R. & Tokgozoglu, L. & 33 others, , 1 Feb 2020, In: Atherosclerosis. 294, p. 80-82 3 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
Open AccessFile
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver